Search JIM Advanced Search

Journal of Integrative Medicine ›› 2014, Vol. 12 ›› Issue (2): 67-75.doi: 10.1016/S2095-4964(14)60019-4

Special Issue: Traditional Chinese Medicine

• Review •     Next Articles

The roles of traditional Chinese medicine in gene therapy

Chang-quan Linga,b, Li-na Wanga, Yuan Wanga,b, Yuan-hui Zhanga,b, Zi-fei Yina, Meng Wanga,b, Chen Lingc,d   

  1. Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China
    Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32611, USA
     Powell Gene Therapy Center, University of Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, Florida 32611, USA
  • Received:2014-02-26 Accepted:2014-03-07 Online:2014-03-10 Published:2014-03-15

The field of gene therapy has been increasingly studied in the last four decades, and its clinical application has become a reality in the last 15 years. Traditional Chinese medicine (TCM), an important component of complementary and alternative medicine, has evolved over thousands of years with its own unique system of theories, diagnostics and therapies. TCM is well-known for its various roles in preventing and treating infectious and chronic diseases, and its usage in other modern clinical practice. However, whether TCM can be applied alongside gene therapy is a topic that has not been systematically examined. Here we provide an overview of TCM theories in relation to gene therapy. We believe that TCM theories are congruent with some principles of gene therapy. TCM-derived drugs may also act as gene therapy vehicles, therapeutic genes, synergistic therapeutic treatments, and as co-administrated drugs to reduce side effects. We also discuss in this review some possible approaches to combine TCM and gene therapy.

Key words: Gene therapy, Medicine, Chinese traditional, Reviews

[1] Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF . T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years[J]. Science, 1995,270(5235):475-480
doi: 10.1126/science.270.5235.475 pmid: 7570001
[2] Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J . Gene therapy clinical trials worldwide to 2012 — an update[J]. J Gene Med, 2013,15(2):65-77
doi: 10.1002/jgm.2698 pmid: 23355455
[3] Peng Z . Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers[J]. Hum Gene Ther, 2005,16(9):1016-1027
doi: 10.1089/hum.2005.16.1016 pmid: 16149900
[4] Chen SX, Xu WD, Yin GW, Xi W, Chen J, Xu QY, Ma GJ . Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma[J]. Zhonghua Yi Xue Za Zhi, 2010,90(31):2182-2186
[5] Tazawa H, Kagawa S, Fujiwara T . Advances in adenovirus-mediated p53 cancer gene therapy[J]. Expert Opin Biol Ther, 2013,13(11):1569-1583
doi: 10.1517/14712598.2013.845662 pmid: 24107178
[6] Melchiorri D, Pani L, Gasparini P, Cossu G, Ancans J, Borg JJ, Drai C, Fiedor P, Flory E, Hudson I, Leufkens HG, Müller-Berghaus J, Narayanan G, Neugebauer B, Pokrotnieks J, Robert JL, Salmonson T, Schneider CK . Regulatory evaluation of Glybera in Europe – two committees, one mission[J]. Nat Rev Drug Discov, 2013,12(9):719
doi: 10.1038/nrd3835-c1 pmid: 23954897
[7] Bryant LM, Christopher DM, Giles AR, Hinderer C, Rodriguez JL, Smith JB, Traxler EA, Tycko J, Wojno AP, Wilson JM . Lessons learned from the clinical development and market authorization of Glybera[J]. Hum Gene Ther Clin Dev, 2013,24(2):55-64
doi: 10.1089/humc.2013.087 pmid: 23808604
[8] Dong J . The relationship between traditional Chinese medicine and modern medicine[J]. Evid Based Complement Alternat Med, 2013,2013:153148
doi: 10.1155/2013/153148 pmid: 3745867
[9] Chen X, Pei L, Lu J. Filling the gap between traditional Chinese medicine and modern medicine, are we heading to the right direction? Complement Ther Med. 2013; 21(3):272-275.
doi: 10.1016/j.ctim.2013.01.001
[10] Qi FH, Wang ZX, Cai PP, Zhao L, Gao JJ, Kokudo N, Li AY, Han JQ, Tang W . Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection[J]. Drug Discov Ther, 2013,7(6):212-224
[11] Liu ZB, Wang X, Liu HJ, Jin YT, Guo HJ, Jiang ZQ, Li Z, Xu LR . Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges[J]. Chin J Integr Med, 2013,19(8):563-567
doi: 10.1007/s11655-013-1552-1
[12] Lee YW, Chen TL, Shih YR, Tsai CL, Chang CC, Liang HH, Tseng SH, Chien SC, Wang CC. Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer. Cancer. Article first published online: 3 FEB 2014.
[13] Xiong X, Yang X, Liu W, Chu F, Wang P, Wang J . Trends in the treatment of hypertension from the perspective of traditional Chinese medicine[J]. Evid Based Complement Alternat Med, 2013,2013:275279
doi: 10.1155/2013/275279 pmid: 3710609
[14] Wei J, Wu R, Zhao D . Analysis on traditional Chinese medicine syndrome elements and relevant factors for senile diabetes[J]. J Tradit Chin Med, 2013,33(4):473-478
doi: 10.1016/S0254-6272(13)60151-X
[15] Zhao ZQ, Mao JY, Wang XL, Hou YZ . Application and evaluation of Chinese medicine in treatment of chronic heart failure[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2013,33(12):1701-1704
pmid: 24517073
[16] Wang Q. Qi Wang’s collected works of medical papers[M]. Beijing: Encyclopedia of China Publishing House, 1993: 98
[17] Weng L, Du J, He WT, Ling CQ . Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome[J]. J Chin Integr Med, 2012,10(4):406-415
doi: 10.3736/jcim201204
[18] Wei M, Zhao XS, Sun XM, Chen J, Luo R . Differential gene expressions in kidney yang deficiency in individuals with sub-health status[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2011,31(2):248-251
doi: 10.1088/1009-0630/13/1/25 pmid: 21354903
[19] Wei M, Zhao XS, Sun XM, Chen J, Lai MH, Luo R . Comparative study on gene expression of kidney-yin deficiency and kidney-yang deficiency[J]. Shanxi Yi Ke Da Xue Xue Bao, 2012,43(9):652-654
[20] Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K , Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJ, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, Ancliff P, Webb DK, Schmidt M, von Kalle C, Gaspar HB, Thrasher AJ.Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients[J]. J Clin Invest, 2008,118(9):3143-3150
doi: 10.1172/JCI35798
[21] Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M . Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1[J]. J Clin Invest, 2008,118(9):3132-3142
doi: 10.1172/JCI35700
[22] Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M , Kr?mer A, Schw?ble J, Glimm H, Koehl U, Preiss C, Ball C, Martin H, G?hring G, Schwarzwaelder K, Hofmann WK, Karakaya K, Tchatchou S, Yang R, Reinecke P, Kühlcke K, Schlegelberger B, Thrasher AJ, Hoelzer D, Seger R, von Kalle C, Grez M.Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease[J]. Nat Med, 2010,16(2):198-204
doi: 10.1038/nm.2088
[23] Lehrman S . Virus treatment questioned after gene therapy death[J]. Nature, 1999,401(6753):517-518
doi: 10.1038/43977 pmid: 10524611
[24] Marshall E . Gene therapy death prompts review of adenovirus vector[J]. Science, 1999,286(5448):2244-2245
doi: 10.1126/science.286.5448.2244
[25] Mingozzi F, High KA . Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges[J]. Nat Rev Genet, 2011,12(5):341-355
doi: 10.1038/nrg2988 pmid: 21499295
[26] Balazs DA, Godbey W . Liposomes for use in gene delivery[J]. J Drug Deliv, 2011,2011:326497
doi: 10.1155/2011/326497 pmid: 3066571
[27] Zhi D, Zhang S, Cui S, Zhao Y, Wang Y, Zhao D . The headgroup evolution of cationic lipids for gene delivery[J]. Bioconjug Chem, 2013,24(4):487-519
doi: 10.1021/bc300381s pmid: 23461774
[28] Layek B, Singh J . Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier[J]. Biomacromolecules, 2013,14(11):4071-4081
doi: 10.1021/bm401204n
[29] Han Z, Conley SM, Makkia RS, Cooper MJ, Naash MI . DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice[J]. J Clin Invest, 2012,122(9):3221-3226
doi: 10.1172/JCI64833 pmid: 3428101
[30] Jin L, Zeng X, Liu M, Deng Y, He N . Current progress in gene delivery technology based on chemical methods and nano-carriers[J]. Theranostics, 2014,4(3):240-255
doi: 10.7150/thno.6914 pmid: 3915088
[31] Zheng WL, Ma WL . Gene therapy through digestive tract — the elucidation of the mechanism of traditional Chinese medicine[J].Ke Ji Dao Bao, 1994(12):8-11
[32] Verma D, Moghimi B , LoDuca PA, Singh HD, Hoffman BE, Herzog RW, Daniell H.Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice[J]. Proc Natl Acad Sci U S A, 2010,107(15):7101-7106
doi: 10.1073/pnas.0912181107
[33] Xia XW, Li X, Feng GS, Zheng CS, Liang HM, Liu X, Xiong B . Feasibility of a polysaccharide isolated from Bletilla striata used as a gene vector administered through an interventional pathway[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2009,17(18):1832-l835
[34] Pantarotto D, Singh R , McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A.Functionalized carbon nanotubes for plasmid DNA gene delivery[J]. Angew Chem Int Ed Engl, 2004,43(39):5242-5246
doi: 10.1002/anie.200460437 pmid: 15455428
[35] Cheung W, Pontoriero F, Taratula O, Chen AM, He H . DNA and carbon nanotubes as medicine[J]. Adv Drug Deliv Rev, 2010,62(6):633-649
doi: 10.1016/j.addr.2010.03.007 pmid: 20338203
[36] Caicedo HM, Dempere LA, Vermerris W . Template-mediated synjournal and bio-functionalization of flexible lignin-based nanotubes and nanowires[J]. Nanotechnology, 2012,23(10):105605
doi: 10.1088/0957-4484/23/10/105605
[37] Ten E, Ling C, Wang Y, Srivastava A, Dempere LA, Vermerris W . Lignin nanotubes as vehicles for gene delivery into human cells[J]. Biomacromolecules, 2014,15(1):327-338
doi: 10.1021/bm401555p
[38] Or?oli? N . Bee venom in cancer therapy[J]. Cancer Metastasis Rev, 2012,31(1-2):173-194
doi: 10.1007/s10555-011-9339-3 pmid: 22109081
[39] Gajski G, Garaj-Vrhovac V . Melittin: a lytic peptide with anticancer properties[J]. Environ Toxicol Pharmacol, 2013,36(2):697-705
doi: 10.1016/j.etap.2013.06.009 pmid: 23892471
[40] Ogris M, Carlisle RC, Bettinger T, Seymour LW . Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors[J]. J Biol Chem, 2001,276(50):47550-47555
doi: 10.1074/jbc.M108331200
[41] Patnaik S, Gupta KC . Novel polyethylenimine-derived nanoparticles for in vivo gene delivery[J]. Expert Opin Drug Deliv, 2013,10(2):215-228
doi: 10.1517/17425247.2013.744964 pmid: 23252504
[42] Zhang W, Song J, Liang R, Zheng X, Chen J, Li G, Zhang B, Yan X, Wang R . Stearylated antimicrobial peptide melittin and its retro isomer for efficient gene transfection[J]. Bioconjug Chem, 2013,24(11):1805-1812
doi: 10.1021/bc400053b pmid: 24107137
[43] Li DC, Zhong XK, Zeng ZP, Jiang JG, Li L, Zhao MM, Yang XQ, Chen J, Zhang BS, Zhao QZ, Xie MY, Xiong H, Deng ZY, Zhang XM, Xu SY, Gao YX . Application of targeted drug delivery system in Chinese medicine[J]. J Control Release, 2009,138(2):103-112
doi: 10.1016/j.jconrel.2009.05.008 pmid: 19433120
[44] Mao SJ, Hou SX, Jin H, Zhang LK, Jiang B . Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes[J]. Zhongguo Zhong Yao Za Zhi, 2003,28(4):328-331
pmid: 15139140
[45] Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH . Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth[J]. J Clin Invest, 2009,119(9):2830-2842
doi: 10.1172/JCI38842
[46] Li B, Gu W, Zhang C, Huang XQ, Han KQ, Ling CQ . Growth arrest and apoptosis of the human hepato cellular carcinoma cell line BEL-7402 induced by melittin[J]. Onkologie, 2006,29(8-9):367-371
[47] Li M, Li X, Li JC . Possible mechanisms of trichosanthin-induced apoptosis of tumor cells[J]. Anat Rec (Hoboken), 2010,293(6):986-992
doi: 10.1002/ar.21142 pmid: 20225201
[48] Fang EF, Ng TB, Shaw PC, Wong RN . Recent progress in medicinal investigations on trichosanthin and other ribosome inactivating proteins from the plant genus Trichosanthes[J]. Curr Med Chem, 2011,18(28):4410-4417
doi: 10.2174/092986711797200499
[49] Sha O, Niu J, Ng TB, Cho EY, Fu X, Jiang W . Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review[J]. Cancer Chemother Pharmacol, 2013,71(6):1387-1393
doi: 10.1007/s00280-013-2096-y
[50] Shaw PC, Chan WL, Yeung HW, Ng TB . Minireview: trichosanthin — a protein with multiple pharmacological properties[J]. Life Sci, 1994,55(4):253-262
doi: 10.1016/0024-3205(94)00727-6 pmid: 8028444
[51] Peng PP, Huang LM, Wang YL, You CC, Cao WH, Song HM, Tan HX, Wu YZ . Effect of recombinant trichosanthin on proliferation of human cevical cancer Caski cells[J]. Zhongguo Zhong Yao Za Zhi, 2011,36(18):2539-2542
doi: 10.1007/s10570-010-9464-0 pmid: 22256762
[52] Ling C, Lu Y, Cheng B, McGoogan KE, Gee SW, Ma W, Li B, Aslanidi GV , Srivastava A.High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors[J].J Vis Exp, 2011( 49):pii: 2538
[53] Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW , McGoogan KE, Govindasamy L, Zhong L, Agbandje-McKenna M, Srivastava A.Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3[J]. Hum Gene Ther, 2010,21(12):1741-1747
doi: 10.1089/hum.2010.075
[54] Cheng B, Ling C, Dai Y, Lu Y, Glushakova LG, Gee SW , McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, Siemann D, Liu C, Srivastava A, Ling C.Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells[J]. Gene Ther, 2012,19(4):375-384
doi: 10.1038/gt.2011.105
[55] Jin SS, Wu JM, Huang ZM, Wu JS, Shen SJ . Construction of analgesic anti-tumor peptide gene eukaryotic expression vector and its effect on hepatocellular carcinoma cells[J]. Zhonghua Nei Ke Za Zhi, 2010,49(2):154-156
[56] Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, Li J, Bian Z, Liang X, Cai X, Yin Y, Wang C, Zhang T, Zhu D, Zhang D, Xu J, Chen Q, Ba Y, Liu J, Wang Q, Chen J, Wang J, Wang M, Zhang Q, Zhang J, Zen K, Zhang CY . Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA[J]. Cell Res, 2012,22(1):107-126
doi: 10.1038/cr.2011.158
[57] Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY . Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008,18(10):997-1006
doi: 10.1038/cr.2008.282
[58] Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS . Lack of detectable oral bioavailability of plant microRNAs after feeding in mice[J]. Nat Biotechnol, 2013,31(11):965-967
doi: 10.1038/nbt.2737 pmid: 24213763
[59] Chen X, Zen K, Zhang CY . Reply to Lack of detectable oral bioavailability of plant microRNAs after feeding in mice[J]. Nat Biotechnol, 2013,31(11):967-969
doi: 10.1038/nbt.2741
[60] Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C , McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O’Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CY, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Cunningham JM, Srivastava D, Basner-Tschakarjan E, Mingozzi F, High KA, Gray JT, Reiss UM, Nienhuis AW, Davidoff AM.Adenovirus-associated virus vector-mediated gene transfer in hemophilia B[J]. N Engl J Med, 2011,365(25):2357-2365
doi: 10.1056/NEJMoa1108046 pmid: 22149959
[61] McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ . Adeno-associated virus terminal repeat(TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo[J]. Gene Ther, 2003,10(26):2112-2118
doi: 10.1038/
[62] Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X . Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo[J]. Gene Ther, 2003,10(26):2105-2111
doi: 10.1038/
[63] Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN, Tuddenham EG, Kemball-Cook G , McIntosh J, Boon-Spijker M, Mertens K, Davidoff AM.Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver[J]. Blood, 2006,107(7):2653-2661
doi: 10.1182/blood-2005-10-4035
[64] Mitchell AM1, Samulski RJ . Mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors[J]. J Virol, 2013,87(23):13035-13041
doi: 10.1128/JVI.01826-13
[65] Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF . Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus[J]. J Clin Invest, 2000,105(11):1573-1587
doi: 10.1172/JCI8317
[66] Russell DW, Alexander IE, Miller AD . DNA synjournal and topoisomerase inhibitors increase transduction by adeno-associated virus vectors[J]. Proc Natl Acad Sci U S A, 1995,92(12):5719-5723
doi: 10.1073/pnas.92.12.5719
[67] Prasad KM, Xu Y, Yang Z, Toufektsian MC, Berr SS, French BA . Topoisomerase inhibition accelerates gene expression after adeno-associated virus-mediated gene transfer to the mammalian heart[J]. Mol Ther, 2007,15(4):764-771
doi: 10.1038/
[68] Zhang FL, Jia SQ, Zheng SP, Ding W . Celastrol enhances AAV1-mediated gene expression in mice adipose tissues[J]. Gene Ther, 2011,18(2):128-134
doi: 10.1038/gt.2010.120 pmid: 20844567
[69] Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C . Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo[J]. J Integr Med, 2014,12(1):20-34
doi: 10.1016/S2095-4964(14)60003-0
[70] Mitchell AM, Li C, Samulski RJ . Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo[J]. J Virol, 2013,87(8):4571-4583
doi: 10.1128/JVI.03443-12
[71] Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L . Chinese medicinal compound Delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture[J]. World J Gastroenterol, 2007,13(41):5432-5439
doi: 10.3748/wjg.v13.i41.5432
[72] Lu CX, Nan KJ, Nie YL, Hai YN, Jiao M . Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways[J]. Mol Biol Rep, 2010,37(7):3407-3412
doi: 10.1007/s11033-009-9930-7
[73] Zhang KT, Qi XD, Huang L, Yang ZB, Jiang NJ, Zhai HY . Synergistic antitumor effect of adenoviral-mediated p53 gene transfer and Delisheng in an ascitic tumor-bearing mouse model[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi, 2006,13(6):466-468
[74] Xu HX, Huang XE, Li Y, Li CG, Tang JH . A clinical study on safety and efficacy of Aidi injection combined with chemotherapy[J]. Asian Pac J Cancer Prev, 2011,12(9):2233-2236
pmid: 22296362
[75] Shi SL, Cui SZ, Hu WN, Chen BM, Han ML, Ma LB . Observation of curative effect of combination of p53 gene therapy drug with traditional Chinese medicine on primary hepatocellular carcinoma[J]. Xian Dai Zhong Xi Yi Jie He Za Zhi, 2012,21(7):693-694
[76] Du BY, Tan YH, Wu YY, Su N, He YL, Zhong ZJ . Thoughts for establishing suicide — gene therapy combimed with Chinese herbal medicine for tumor[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2002,19(1):1-3
[77] Sangha JS, Sun X, Wally OS, Zhang K, Ji X, Wang Z, Wang Y, Zidichouski J, Prithiviraj B, Zhang J.Liuwei Dihuang ( LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegans[J]. PLoS One, 2012,7(8):e43990
doi: 10.1371/journal.pone.0043990
[78] Liu Y, Zhao H, Zhang J, Zhang P, Li M, Qi F, Wang Y, Kou S, Zheng Q, Wang L . The regulatory effect of Liuwei Dihuang Pills on cytokines in mice with experimental autoimmune encephalomyelitis[J]. Am J Chin Med, 2012,40(2):295-308
doi: 10.1142/S0192415X12500231
[79] Yi H, Du BY, Tan YH, Sun J, Wu YY, Li JF, Guo J . Investigate the mechanism of Liuwei Dihuang Bolus enhancing hepatocarcinoma suicide gene therapy from Cx26[J]. Zhonghua Zhong Yi Yao Za Zhi, 2009,24(9):1200-1204
[80] Du BY, Zhang AJ, Tan YH, Yi H, Wu YY . Synergistic killing action of suicide gene system combined with medicated serum of Liuwei Dihuang Bolus on hepatoma cells[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2008,25(4):319-323
[81] Yi H, Guo YR, Du BY, Tan YH, Wu YY . Enhancement of Liuwei Dihuang Bolus on bystander effect of HSV-tk/GCV suicide gene therapy for mice melanoma cells[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2010,27(5):498-501
[82] Yi H, Du BY, Tan YH, Liu AJ, Luo H, Luo XX, Su JF, Wang HF . Joint therapeutic effect of hepatocarcinoma suicide gene therapy combined with Liuwei Dihuangwan on expression of connexin in vitro[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2011,17(12):114-118
[83] Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H . Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells[J]. Cancer Gene Ther, 2005,12(7):600-607
doi: 10.1038/sj.cgt.7700826 pmid: 15775995
[84] Portsmouth D, Hlavaty J, Renner M . Suicide genes for cancer therapy[J]. Mol Aspects Med, 2007,28(1):4-41
doi: 10.1016/j.mam.2006.12.001 pmid: 17306358
[85] Liu JP, Tian X, Liu HY, Zhang QH, Lu D, Li PY, Zhao CF . Two novel dammarane-type compounds from the leaves and stems of Panax quinquefolium L[J]. J Asian Nat Prod Res, 2013,15(9):974-978
doi: 10.1080/10286020.2013.794416 pmid: 24266579
[86] Son YM, Kwak CW, Lee YJ, Yang DC, Park BC, Lee WK, Han SH, Yun CH . Ginsenoside Re enhances survival of human CD4+ T cells through regulation of autophagy[J]. Int Immunopharmacol, 2010,10(5):626-631
doi: 10.1016/j.intimp.2010.03.002 pmid: 20230918
[87] Li YJ, Du BY, Tan YH, Wu YY, Luo H, Zhang GX, Shao HW, He PY . Synergistic effect of ginsenosides on HSV-tk/GCV system in treating murine transplanted melanoma[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2011,28(4):382-385
[88] He C, Wu T, Hu XT, Liang JH, Chen P . Tumor suppression activity of ginsenoside Rg3 combined with TRAIL gene on human colon cancer cell line HCE8693[J]. Zhongguo Yao Xue Za Zhi, 2004,39(8):599-601
[89] Zhang L, Zeng QQ, Lin JH . Inhibitory effect of human P27KIP1 gene AVV virus combining with Chinese herb Pien Tze Huang on human osteosarcoma transplant mice model[J]. Zhonghua Zhong Yi Yao Za Zhi, 2009,24(4):511-515
[90] Wang CJ, Li JJ, Chen ZB, Liu YZ, Xu XM, Deng L, Pan JQ . Chinese herbs of invigorating the spleen and removing blood stasis(JPHY) improve killing effects of CD/TK double suicide genes on human hepatocellular carcinoma[J]. Xian Dai Sheng Wu Yi Xue Jin Zhan, 2008,8(9):1605-1607
[91] Wang G, Zhou J, Feng KK, Tian L . Anti-angiogenesis effect of adeno-associated virus mediated recombinant angiostatin combined with celastrol on intracranial C6 glioma in rats[J]. Zhong Liu, 2011,31(10):875-880
[92] .[ OTHER].Zhang LJ. Induced apoptosis of human hepatoma carcinoma cell SMMC7721 by periplocin and STAT3siRNA. Shijiazhuang: Hebei Medical University. 2008. Chinese with abstract in English.
[93] Zhang J, Shan BE, Li QM, Zhang C, Zhao RN, Ai J . Immunoregulatory effects of periplocin from Cortex Periplocae in tumor-bearing mice[J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2009,25(10):887-890
pmid: 19811733
[94] Lu ZJ, Zhou Y, Song Q, Qin Z, Zhang H, Zhou YJ, Gou LT, Yang JL, Luo F . Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways[J]. Cell Physiol Biochem, 2010,26(4-5):609-618
doi: 10.1159/000322328
[95] Li ZQ, Tan Q, Ding ZX, Liu D . Mechanism of DADS in the bystander effect of HSV-tk/GCV suicide gene therapy system in lens epithelial cells[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2011,36(4):329-334
[96] Meyer-Hamme G, Beckmann K, Radtke J, Efferth T, Greten HJ, Rostock M , Schrder S.A survey of Chinese medicinal herbal treatment for chemotherapy-induced oral mucositis[J]. Evid Based Complement Alternat Med, 2013,2013:284959
doi: 10.1155/2013/284959 pmid: 3830834
[1] Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[3] Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375.
[4] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[5] Vibha Malhotra, Joanna Harnett, Erica McIntyre, Amie Steel, Keith Wong, Bandana Saini. To “tell or not to tell”—Exploring disclosure about medicine use by people living with sleep disorders. Journal of Integrative Medicine, 2022, 20(4): 338-347.
[6] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[7] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[8] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[9] Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.
[10] Mohammad Fazil, Sadia Nikhat. Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective. Journal of Integrative Medicine, 2022, 20(2): 91-95.
[11] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[12] Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33.
[13] Mahlagha Dehghan, Alireza Ghanbari, Fatemeh Ghaedi Heidari, Parvin Mangalian, Mohammad Ali Zakerid. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. Journal of Integrative Medicine, 2022, 20(1): 45-51.
[14] Jose Antonio Castilla-Jimena, Isabel Ruiz-Pérez, Jesús Henares-Montiel. Impact of socioeconomic and health-related factors on consumption of homeopathic and natural remedies in Spain in 2006, 2011 and 2017. Journal of Integrative Medicine, 2022, 20(1): 52-56.
[15] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022